No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
CA Stock MarketDetailed Quotes
APS Aptose Biosciences Inc
- 0.900
- +0.010+1.12%
15min DelayTrading Jul 23 10:31 ET
16.30MMarket Cap-109P/E (TTM)
0.900High0.900Low597Volume0.900Open0.890Pre Close532.20Turnover6.90052wk High0.00%Turnover Ratio18.11MShares0.80052wk Low-8.246EPS TTM16.30MFloat Cap47520.000Historical HighLossP/E (Static)18.11MShs Float0.800Historical Low-10.048EPS LYR0.00%Amplitude--Dividend TTM90.00P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Aptose Biosciences Faces Nasdaq Delisting Challenge
Aptose Announces Receipt of Deficiency Notice From Nasdaq
Aptose Announces Results From Annual and Special Meeting of Shareholders
Press Release: Aptose Announces Results From Annual and Special Meeting of Shareholders
H.C. Wainwright Maintains Aptose Biosciences(APTO.US) With Buy Rating, Maintains Target Price $7
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
Heat List
CA
Overall
Symbol
Latest Price
%Chg